Objective To study the associations between prenatal exposures and risk of developing polycystic ovary syndrome (PCOS).
Introduction
Polycystic ovary syndrome (PCOS) is an endocrine condition affecting 6-10% of women, 1 and besides polycystic ovarian morphology the syndrome is associated with menstrual irregularity and hyperandrogenism. 2 Women with PCOS frequently present with infertility, central adiposity, and insulin resistance, and have an increased risk of developing type-2 diabetes mellitus. 3 The etiology of PCOS is multifactorial and not fully understood. Evidence suggests that both heritable and environmental factors play a role in the pathogenesis of PCOS. 4 Several genes associated with PCOS have been identified, [5] [6] [7] and diverse genes seem responsible for different phenotypes of PCOS, 8 implying a complex genetic disorder. Ethnicity, family history, and lifestyle also influence the risk of PCOS. [9] [10] [11] Obesity and greater weight gain are associated with PCOS, 12 and smoking increases the free androgen index in women with PCOS. 13 It is possible that various factors affecting the female fetus in the intrauterine period contribute to the development of PCOS later in life. For instance, increased levels of testosterone during fetal life have been suggested to be involved in PCOS pathogenesis. A number of animal models have been used, demonstrating that sheep, monkeys, rats, and mice treated with testosterone or dihydro-testosterone prenatally exhibit ovarian and endocrine traits similar to women with PCOS, such as luteinising hormone hypersecretion, enlarged polyfollicular ovaries, and functional hyperandrogenism. [14] [15] [16] [17] [18] [19] Some human studies have suggested that high and low birthweights are associated with an increased risk of developing PCOS, 4, 20, 21 whereas other studies have not shown such an association. [22] [23] [24] One study indicated that women whose mothers had diabetes had a higher risk of being diagnosed with PCOS. 4 Apart from these exposures, data are essentially lacking for humans.
We thus designed this study to investigate whether prenatal exposures were associated with the risk of developing PCOS in women.
Methods
The Swedish National Board of Health and Welfare gave access to information from the Swedish medical birth registry, patient registry, and cause of death registry. Statistics Sweden provided data from the education registry and the total population registry. Individual record linkage between the registries was possible through each individual's unique personal registration number, which is assigned to Swedish residents at birth or upon immigration. 25 The birth registry contains data on 98% of all births in Sweden since 1973, and includes prospectively collected demographic data, information on reproductive history, and complications that occur during pregnancy, delivery, and the neonatal period. In Sweden, antenatal care is standardised and free of charge. 25 During the first antenatal visit, usually taking place at the end of the first trimester, the mother is interviewed about her medical and obstetric history, including her height and current smoking habits. Data on some chronic diseases (such as pre-gestational diabetes) and smoking habits are recorded by check boxes. Maternal weight is measured wearing light indoor clothing. Complications during pregnancy and delivery are classified according to the International Classification of Diseases (ICD), as noted by the responsible obstetrician at discharge from the delivery hospital. Information on each pregnancy and delivery is forwarded to the birth registry through copies of standardised antenatal, obstetric, and paediatric records.
The patient registry includes information on dates of hospital admissions and diagnoses since the 1960s, with full national coverage since 1987. 26 Since 2001 the registry also covers specialised outpatient visits, including visits to a gynaecologist or reproductive specialist. Diagnoses are classified according to ICD codes.
Study population
All singleton, live-born girls between 1 January 1982 and 31 December 1995 who reached at least 15 years of age were included in the study population. All births from the Swedish medical birth register during this period included 1 505 061 births. We excluded 823 938 births because of multiple pregnancies (n = 34 821), male gender or unknown sex of the child (n = 755 838), stillborn (n = 2428), incorrect or missing personal identification number (n = 2569), death before 15 years of age (n = 4547), emigration before 15 years of age (n = 23 643), and PCOS diagnosis before 15 years of age (n = 92). Of 681 123 births to women that were eligible for analysis, 3738 girls received a PCOS diagnosis and 677 385 had no PCOS diagnosis ( Figure S1 ). The height and weight of mothers were registered in the birth registry for 1982-1989, and from 1992 onwards, enabling the calculation of early pregnancy body mass index (BMI). Data on smoking habits in early pregnancy and years of involuntary childlessness before the index pregnancy have been recorded in the birth registry since 1982. Information on gestational diabetes was only available from 1989 onwards. We started to follow the offspring in the patient registry when they turned 15 years of age, and we were able to follow the population to a maximum of 28 years of age at the end of 2010.
Variables
We collected data from the Swedish birth registry on maternal height, weight, smoking habits, age at delivery, parity, and involuntary childlessness before the index pregnancy, presence of pre-eclampsia or diabetes during the index pregnancy, and the offspring's size and gestational age at birth. Pre-eclampsia and pre-gestational diabetes were identified by ICD codes, and pre-gestational diabetes was further identified by the check box from the first antenatal visit. Diagnoses are coded according to the Swedish versions of the ICD. ICD version 7 was applicable between 1964 and 1968, version 8 between 1969 and 1986, version 9 between 1987 and 1996, and version 10 from 1997 onwards. Pre-eclampsia was defined as ICD-8 code 637.03-99 and ICD-9 code 642E-G. Pre-gestational diabetes was defined by a mark in a corresponding check box at the first antenatal visit and/or ICD-8 codes 250 and 761.1 and ICD-9 codes 250 and 648A. Gestational diabetes was only available in ICD 9, code 648W. We had different definitions to estimate offspring size at birth. First, we categorised by birthweight (<2500, 2500-4499, ≥4500 g). Second, we categorised standardised birthweights according to gestational age and sex-specific Swedish birthweight curves. 27 Appropriate for gestational age (AGA) describes infants whose weight is within the normal range for gestational age. Small for gestational age (SGA) were infants with birthweight below the 10th percentile for the gestational age, and large for gestational age (LGA) were infants with birthweight above the 90th percentile. Ultrasound estimation of gestational age was introduced in Sweden during the mid-1980s. If no ultrasound scan was available, the first day of the last menstrual period was used to calculate gestational age at delivery. Thirdly, we calculated the ponderal index, defined as birthweight/height3 9 100. Low and high ponderal indices were defined as a ponderal index score among the 10% lowest or highest in the study population. Finally, we calculated the head circumference for gestational age. Small and large head circumference for gestational age were defined as more than 10% below the mean head circumference for gestational age, respectively, according to the Swedish reference curve for newborn infants. 28 Variables were categorised as shown in Tables 1 and 2 .
Data on maternal education in 2010, country of birth, and maternal PCOS diagnosis were collected from the education registry, the registry of the total population, and the patient registry, respectively. Variables were categorised as maternal education of ≤11 years or ≥12 years, maternal country of birth as Nordic or non-Nordic, and whether the mother had diagnosis of PCOS or not (during the years 1964 to 2010). Until 1990 the criteria for Stein-Leventhal syndrome was used for the diagnosis of PCOS syndrome in Sweden. In 1990 the US National Institutes of Health (NIH) criteria was introduced for PCOS diagnosis. According to the NIH the woman needs to fulfil both of these criteria for a diagnosis of PCOS: clinical or biochemical hyperandrogenism and chronic anovulation. 29 From 2003, the Rotterdam criteria were swiftly introduced into clinical practice in Sweden. Even so, the NIH criteria are still in practice in adolescent girls, when transvaginal ultrasound is considered unfeasible. According to the Rotterdam criteria the woman needs to fulfil two of three criteria for PCOS diagnosis: oligo-or anovulation, clinical or biochemical hyperandrogenism, and polycystic morphology of the ovaries.
2 PCOS diagnosis was defined as ICD-7 code 275.20, ICD-8 code 256.90, ICD-9 code 256E, and ICD-10 code E28.2. In the Swedish version of ICD 7 and ICD 8 the codes correspond to the formerly known SteinLeventhals syndrome. For versions ICD 9 and ICD 10 the code is specified as PCOS and Stein-Leventhals syndrome.
The primary outcome variable was a PCOS diagnosis in the offspring at ≥15 years of age. The PCOS diagnosis was retrieved from the patient registry.
Statistical analyses
Cox regression analysis was used to estimate hazard ratios (HRs) with 95% confidence intervals (95% CIs) for the association between maternal and newborn characteristics and the risk of a PCOS diagnosis in the offspring. The Schoenfeld residuals test was performed and showed fitness for the variables in the model. Adjustments were made for all maternal characteristics (Table 1) when testing each variable in turn. As information on BMI was missing in many cases before 1992, we re-ran our analyses without the inclusion of BMI in our model. We thereafter estimated the association between maternal smoking and birthweight for gestational age and risk of PCOS diagnosis in those with and those without maternal BMI data.
The statistical software package SAS 9.4 (version 6.1; SAS, Cary, NC, USA) was used for the analysis. 
Results
In the final cohort of 681 123 girls, 3738 (0.54%) had been diagnosed with PCOS. In total, the follow-up included 4 516 270 person years.
Bivariate comparisons of maternal characteristics by offspring diagnosis of PCOS are presented in Table 1 . Girls who developed PCOS more frequently had mothers with BMIs in the higher categories, who smoked during pregnancy, were younger, primiparous, and had more years of involuntary childlessness before the index pregnancy, than girls without PCOS. Mothers of girls with PCOS more often also had a lower educational level, were more often born in non-Nordic countries, and had more often been diagnosed with PCOS themselves (1.2%, compared with 0.2% of mothers to girls without PCOS). Pre-gestational diabetes, gestational diabetes, or pre-eclampsia were not more common in mothers of PCOS offspring, however.
Bivariate comparisons of birth indices by PCOS status are presented in Table 2 . Girls who later developed PCOS were more often born SGA, thinner at birth, and had smaller head circumferences than those without PCOS. Birthweights of <2500 g and preterm birth (<37 weeks of gestation) were not associated with a later diagnosis of PCOS. Table 3 illustrates the adjusted associations between maternal characteristics and a later diagnosis of PCOS. A dose-response pattern was noted between maternal BMI and maternal smoking in the index pregnancy and risk of PCOS diagnosis in the offspring. The adjusted risk for PCOS was increased 1.97-fold if the mother was obese (BMI ≥ 30 kg/m 2 ), compared with mothers with normal BMI, and the risk was increased by 1.44-fold if the mother was a heavy smoker compared with a non-smoker. Mothers born in a non-Nordic country and mothers with PCOS more commonly gave birth to a girl who developed PCOS. There were no associations between maternal age, parity, involuntary childlessness, diabetes, or pre-eclampsia in the index pregnancy and the development of PCOS in the offspring. Table 4 illustrates the unadjusted and adjusted associations between birth indices and a later diagnosis of PCOS. According to the unadjusted hazard ratio, being born SGA *Small and large birthweights for gestational age were defined as a birthweights of more than 10% below or above the mean weight for gestational age, respectively, according to the Swedish sexspecific fetal growth curve (Marsal) . **Low and high ponderal indices were defined as a ponderal index score of approximately 10% lower or higher than the mean ponderal index in the study population. ***Small and large head circumferences for gestational age were defined as more than 10% below or above, respectively, the mean head circumference according to the Swedish reference curve for newborn infants (Niklasson) .
as well as having a small head circumference for gestational age increased the risk of PCOS later in life. After adjusting for maternal characteristics, the associations were attenuated and no longer significant. Table S1 illustrates the stratified analyses on women with and without information about BMI. The effect of maternal smoking and birthweight for gestational age on a PCOS diagnosis in female offspring was similar, independent of whether information about BMI was available or not.
Discussion

Main findings
In this large population-based cohort we found associations between maternal obesity and smoking during pregnancy and a later diagnosis of PCOS in the offspring. Being born SGA and having a small head circumference for gestational age were both associated with a later diagnosis of PCOS in crude estimates, and the associations seemed to be mediated by maternal factors.
Strength and limitations
An important strength of this study is the large size of the cohort, including a whole country, which enabled us to assess more prenatal exposures than in former studies. 4, [20] [21] [22] 24 Information on the exposure variables was prospectively collected through the birth registry, which limits recall bias. Free and standardised antenatal and delivery care minimised the possibility of residual confounding, and increased the generalisability of the results.
A major limitation of the study is the low prevalence of PCOS, of 0.54%, compared with the 5-10% in studies that have aimed to report the prevalence of PCOS. 1 This low prevalence depends on the register-based study design, and is in line with the prevalence of PCOS reported in studies with similar design. 4, 30 Thus, only women who sought medical care for their symptoms and were diagnosed with PCOS in hospitals (as inpatients or outpatients) were included, which could lead to the misclassification of women with PCOS to the non-PCOS groups, which could drive our estimates towards no real difference. Furthermore, our cases of PCOS received their diagnosis before the age of 28 years. Irregular menstruation and polycystic morphology of the ovaries are more common in adolescents, and therefore it is important for clinicians to only set the PCOS diagnosis in the juvenile population when PCOS symptoms are severe and clinically important. Earlier studies have shown that young patients with a diagnosis of PCOS are likely to reflect the more extreme end of the clinical presentations associated with PCOS, including severe ovulatory dysfunction and hirsutism. 31 Our results are therefore presumably more likely to be generalisable to the most severe PCOS phenotypes. Information on BMI was missing in one-third of the women, largely because BMI was not collected in the maternal report for a certain period of years; however, when we performed a stratified analysis on women with and without information about BMI, our results were similar in both groups, indicating that this did not influence the findings.
Interpretations
Our results indicate that a high maternal BMI is an independent risk factor for the later development of PCOS in the offspring. This may be a direct or indirect effect of maternal fat tissue synthesis and secretion of adipocytokines, or of raised or altered inflammatory factor profiles, disturbed glucose metabolism, or hormonal effects on the fetus, but it could also be a consequence of genetic factors. An abundance of fat tissue may also have direct effects on the placenta. Placental mitochondrial dysfunction, reduced mitochondrial biogenesis, and a decrease in placental ATP levels have been noted in women who are overweight or obese. 32 Furthermore, it was recently demonstrated that obesity interferes with the initial steps of placental cholesterol metabolism, leading to lower estradiol and progesterone synthesis. 33 In addition, BMI is positively correlated with maternal testosterone levels during pregnancy, 34 and maternal weight gain is associated with amniotic fluid testosterone levels in female fetuses. 35 Such effects of maternal obesity may affect the fetal hormonal profile and, in turn, influence PCOS development in the offspring. Presumably, daughters to women with high BMIs have similar nutritional habits as their mothers, which by itself could increase their risk of overweight and obesity, and thereby their risk of developing PCOS. In this study we did not have information on the BMIs of the grown-up female offspring to substantiate such a relationship.
In the present study we also noted a dose-dependent association between maternal smoking and offspring PCOS diagnosis, even after adjustment for maternal BMI, educational level, and maternal PCOS diagnosis. Maternal smoking has not previously been associated with a risk for PCOS, but it has been associated with decreased levels of reproductive hormones, 36 and reduced fertility in the adult female offspring. 37 Smoke-exposed fetal ovaries exhibit a higher density of primordial follicles, 38 reduced germ cell and somatic cell proliferation, [39] [40] [41] and genes important for ovarian development are dysregulated, 38 suggesting that maternal smoking may have direct effects on fetal ovaries.
Association with the development of PCOS and relative birthweight was noted. Prior studies in this area have been inconsistent, demonstrating that both high and low birthweights are associated with the development of PCOS. 4, 20, 21 Melo et al. 21 reported a higher prevalence of PCOS in women born SGA than in women born AGA. Davies et al. 20 did not find a higher prevalence of PCOS in SGA or LGA infants, but reported that a low ponderal index was associated with all three diagnostic criteria for PCOS. In a large cohort study, Mumm et al. 4 observed an association between PCOS and high birthweights, but not with birthweight when adjusted for gestational age. We did not observe an association between later PCOS and actual birthweight, which is consistent with several other studies. 22, 24, 42, 43 In our crude analysis we demonstrate an association between later PCOS and low birthweight for gestational age and small head circumference for gestational age, however. This replication of relative size at birth and the development of PCOS clearly points to the importance of antenatal factors for the fully expressed syndrome. After *Adjusted for all maternal characteristics (maternal age, parity, years of involuntary childlessness before index pregnancy, and presence of diabetes or pre-eclampsia at index pregnancy, as well as for maternal education level, country of birth, and PCOS diagnosis). **Small and large birthweights for gestational age were defined as birthweights of more than 10% below or above the mean birthweight for gestational age, respectively, according to the Swedish sex-specific fetal growth curve (Marsal) . ***Low and high ponderal indices were defined as a ponderal index score among the approximately 10% lower or higher ponderal index in the study population. ****Small and large head circumferences for gestational age were defined as more than 10% below or above, respectively, the mean head circumference according to the Swedish reference curve for newborn infants (Niklasson) .
adjustment for maternal factors like ethnicity, country of birth, maternal PCOS diagnosis, or pre-eclampsia in the index pregnancy, the association was attenuated and no longer significant in the present study. This finding indicates that maternal factors might be the underlying cause of the association between relative size at birth and the development of PCOS.
Conclusions
Factors during intrauterine life, such as maternal smoking and obesity, may influence the risk for a later diagnosis of PCOS in the offspring. Hopefully it will be possible to restrict maternal smoking or obesity with education and interventions in primary maternal care, or even at family planning. Being born SGA was associated with the development of PCOS, and the association appears to be mediated by maternal factors. Other factors during pregnancy may influence birthweight, and in future studies we plan to examine whether testosterone levels during pregnancy are correlated with birthweight.
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